Publications by authors named "Tomas Gabriel Bas"

Claim this Profile
F
Formulation of Recombinant Therapeutic Proteins: Technological Innovation, Regulations, and Evolution Towards Buffer-Free Formulations.
Tomas Gabriel Bas

Pharmaceutics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges.
Tomas Gabriel Bas

Pharmaceuticals (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivity and Bioavailability of Carotenoids Applied in Human Health: Technological Advances and Innovation.
Tomas Gabriel Bas

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars in the Era of Artificial Intelligence-International Regulations and the Use in Oncological Treatments.
Tomas Gabriel Bas, Vannessa Duarte

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustainable Development versus Extractivist Deforestation in Tropical, Subtropical, and Boreal Forest Ecosystems: Repercussions and Controversies about the Mother Tree and the Mycorrhizal Network Hypothesis.
Tomas Gabriel Bas, Mario Luis Sáez, Nicolas Sáez

Plants (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars for the next decade in Latin America: a window of opportunity.
Tomas Gabriel Bas

Expert Opin Biol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinions Related to the Potential Application of Artificial Intelligence (AI) by the Responsible in Charge of the Administrative Management Related to the Logistics and Supply Chain of Medical Stock in Health Centers in North of Chile.
Tomas Gabriel Bas, Paula Astudillo, Daniel Rojo, Angel Trigo

Int J Environ Res Public Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovation strategy management survey of the Chilean biomedical industry. Assessment of windows of opportunities to reduce technological gaps.
Tomas Gabriel Bas, Carolina Alejandra Oliu

Int J Health Plann Manage· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars in Developed and Developing East and Southeast Asian Countries: Japan, South Korea, and Malaysia-Overview, Evolution, and Regulations Assessment.
Tomas Gabriel Bas, Carolina Oliu Castillo

Biomed Res Int· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis